Giordano Christopher Thomas bought TENX
May 17, 2024 · Form 4 insider transaction
Giordano Christopher Thomas bought 437 shares of Tenax Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
437
Price
$0.00
Total value
N/A
InsiderGiordano Christopher Thomas
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 17, 2024
Filing dateMay 21, 2024
Shares owned after437
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment.